Generic placeholder image

Current Pharmaceutical Design


ISSN (Print): 1381-6128
ISSN (Online): 1873-4286

Spongistatins as Tubulin Targeting Agents

Author(s): F. M. Uckun, C. Mao, S. -T. jan, H. Huang, A. O. Vassilev, C. S. Navara and R. K. Narla

Volume 7, Issue 13, 2001

Page: [1291 - 1296] Pages: 6

DOI: 10.2174/1381612013397492

Price: $65


Recently identified novel agents that disrupt tubulin polymerization include synthetic spiroketal pyrans (SPIKET) targeting the spongistatin binding site of beta tubulin. These agents exhibit anticancer activity by disrupting normal mitotic spindle assembly and cell division as well as inducing apoptosis. At nanomolar concentrations, the SPIKET compound SPIKET-P caused tubulin depolymerization in cell-free turbidity assays and exhibited potent cytotoxic activity against cancer cells as evidenced by destruction of microtubule organization, and prevention of mitotic spindle formation in human breast cancer cells. SPIKET compounds represent a new class of tubulin targeting agents that show promise as anti-cancer drugs.

Keywords: Spongistatins, Tubulin Targeting Agents, spiroketal pyrans (SPIKET), anticancer activity, SPIKET, SPIKET-P, anti-cancer drugs, Spiroketal Pyrans (SPIKET-P), Beta Tubulin, colchicine

Rights & Permissions Print Cite
© 2024 Bentham Science Publishers | Privacy Policy